Global Targeted Radiopharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 124
Published Date: 08 Aug 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Targeted Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Targeted radiopharmaceuticals are a type of medicinal product that combines a biologically active molecule (known as a ligand or targeting agent) with a radioactive isotope (radionuclide). These radiopharmaceuticals are designed to deliver radiation specifically to certain cells, tissues, or organs in the body, with the goal of achieving precise and localized treatment or imaging.
The concept of targeted radiopharmaceuticals is based on the idea of using the biological specificity of the ligand to selectively bind to receptors or antigens present on the target cells. Once the ligand has bound to its target, the radioactive component emits radiation that can be used for therapeutic purposes or imaging.There are two main categories of targeted radiopharmaceuticals: targeted therapeutic radiopharmaceuticals and targeted diagnostic radiopharmaceuticals.
Targeted radiopharmaceuticals offer several advantages over traditional treatments or imaging agents, including increased specificity, reduced damage to healthy tissues, and the potential for personalized medicine approaches based on the patient's specific disease characteristics. However, the development and use of targeted radiopharmaceuticals require careful consideration of the ligand's biological properties, radionuclide characteristics, and safety profiles to ensure effective and safe medical applications.
The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
The Global Info Research report includes an overview of the development of the Targeted Radiopharmaceuticals industry chain, the market status of Targeted Therapy (Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), Targeted Diagnosis (Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Radiopharmaceuticals.
Regionally, the report analyzes the Targeted Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Radiopharmaceuticals market.
Regional Analysis: The report involves examining the Targeted Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Radiopharmaceuticals:
Company Analysis: Report covers individual Targeted Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Targeted Therapy, Targeted Diagnosis).
Technology Analysis: Report covers specific technologies relevant to Targeted Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Targeted Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Targeted Therapeutic Radiopharmaceuticals
Targeted Diagnostic Radiopharmaceuticals
Market segment by Application
Targeted Therapy
Targeted Diagnosis
Major players covered
Novartis
Bayer
Lantheus
Institute for Radioelements (IRE)
Radiomedix
Curium Pharma
Clarity Pharmaceuticals
ROTOP
Ratio Therapeutics
Fusion Pharmaceuticals
Perspective Therapeutics
RayzeBio
Alpha-9 Theranostics
Radiopharm Theranostics
Telix Pharmaceuticals
Ariceum Therapeutics
Aktis Oncology
Navidea Biopharmaceuticals
Nucleus RadioPharma
SmartNuclide Biopharma
TetraKit Technologies
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Radiopharmaceuticals, with price, sales, revenue and global market share of Targeted Radiopharmaceuticals from 2018 to 2023.
Chapter 3, the Targeted Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Targeted Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Radiopharmaceuticals.
Chapter 14 and 15, to describe Targeted Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Targeted Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Radiopharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Targeted Therapeutic Radiopharmaceuticals
1.3.3 Targeted Diagnostic Radiopharmaceuticals
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeted Radiopharmaceuticals Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Targeted Therapy
1.4.3 Targeted Diagnosis
1.5 Global Targeted Radiopharmaceuticals Market Size & Forecast
1.5.1 Global Targeted Radiopharmaceuticals Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Targeted Radiopharmaceuticals Sales Quantity (2018-2029)
1.5.3 Global Targeted Radiopharmaceuticals Average Price (2018-2029)
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Targeted Radiopharmaceuticals Product and Services
2.1.4 Novartis Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Targeted Radiopharmaceuticals Product and Services
2.2.4 Bayer Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer Recent Developments/Updates
2.3 Lantheus
2.3.1 Lantheus Details
2.3.2 Lantheus Major Business
2.3.3 Lantheus Targeted Radiopharmaceuticals Product and Services
2.3.4 Lantheus Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lantheus Recent Developments/Updates
2.4 Institute for Radioelements (IRE)
2.4.1 Institute for Radioelements (IRE) Details
2.4.2 Institute for Radioelements (IRE) Major Business
2.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
2.4.4 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Institute for Radioelements (IRE) Recent Developments/Updates
2.5 Radiomedix
2.5.1 Radiomedix Details
2.5.2 Radiomedix Major Business
2.5.3 Radiomedix Targeted Radiopharmaceuticals Product and Services
2.5.4 Radiomedix Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Radiomedix Recent Developments/Updates
2.6 Curium Pharma
2.6.1 Curium Pharma Details
2.6.2 Curium Pharma Major Business
2.6.3 Curium Pharma Targeted Radiopharmaceuticals Product and Services
2.6.4 Curium Pharma Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Curium Pharma Recent Developments/Updates
2.7 Clarity Pharmaceuticals
2.7.1 Clarity Pharmaceuticals Details
2.7.2 Clarity Pharmaceuticals Major Business
2.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
2.7.4 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Clarity Pharmaceuticals Recent Developments/Updates
2.8 ROTOP
2.8.1 ROTOP Details
2.8.2 ROTOP Major Business
2.8.3 ROTOP Targeted Radiopharmaceuticals Product and Services
2.8.4 ROTOP Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ROTOP Recent Developments/Updates
2.9 Ratio Therapeutics
2.9.1 Ratio Therapeutics Details
2.9.2 Ratio Therapeutics Major Business
2.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
2.9.4 Ratio Therapeutics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ratio Therapeutics Recent Developments/Updates
2.10 Fusion Pharmaceuticals
2.10.1 Fusion Pharmaceuticals Details
2.10.2 Fusion Pharmaceuticals Major Business
2.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
2.10.4 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Fusion Pharmaceuticals Recent Developments/Updates
2.11 Perspective Therapeutics
2.11.1 Perspective Therapeutics Details
2.11.2 Perspective Therapeutics Major Business
2.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
2.11.4 Perspective Therapeutics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Perspective Therapeutics Recent Developments/Updates
2.12 RayzeBio
2.12.1 RayzeBio Details
2.12.2 RayzeBio Major Business
2.12.3 RayzeBio Targeted Radiopharmaceuticals Product and Services
2.12.4 RayzeBio Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 RayzeBio Recent Developments/Updates
2.13 Alpha-9 Theranostics
2.13.1 Alpha-9 Theranostics Details
2.13.2 Alpha-9 Theranostics Major Business
2.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
2.13.4 Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Alpha-9 Theranostics Recent Developments/Updates
2.14 Radiopharm Theranostics
2.14.1 Radiopharm Theranostics Details
2.14.2 Radiopharm Theranostics Major Business
2.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
2.14.4 Radiopharm Theranostics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Radiopharm Theranostics Recent Developments/Updates
2.15 Telix Pharmaceuticals
2.15.1 Telix Pharmaceuticals Details
2.15.2 Telix Pharmaceuticals Major Business
2.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
2.15.4 Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Telix Pharmaceuticals Recent Developments/Updates
2.16 Ariceum Therapeutics
2.16.1 Ariceum Therapeutics Details
2.16.2 Ariceum Therapeutics Major Business
2.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
2.16.4 Ariceum Therapeutics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ariceum Therapeutics Recent Developments/Updates
2.17 Aktis Oncology
2.17.1 Aktis Oncology Details
2.17.2 Aktis Oncology Major Business
2.17.3 Aktis Oncology Targeted Radiopharmaceuticals Product and Services
2.17.4 Aktis Oncology Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Aktis Oncology Recent Developments/Updates
2.18 Navidea Biopharmaceuticals
2.18.1 Navidea Biopharmaceuticals Details
2.18.2 Navidea Biopharmaceuticals Major Business
2.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
2.18.4 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Navidea Biopharmaceuticals Recent Developments/Updates
2.19 Nucleus RadioPharma
2.19.1 Nucleus RadioPharma Details
2.19.2 Nucleus RadioPharma Major Business
2.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
2.19.4 Nucleus RadioPharma Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Nucleus RadioPharma Recent Developments/Updates
2.20 SmartNuclide Biopharma
2.20.1 SmartNuclide Biopharma Details
2.20.2 SmartNuclide Biopharma Major Business
2.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
2.20.4 SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 SmartNuclide Biopharma Recent Developments/Updates
2.21 TetraKit Technologies
2.21.1 TetraKit Technologies Details
2.21.2 TetraKit Technologies Major Business
2.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
2.21.4 TetraKit Technologies Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 TetraKit Technologies Recent Developments/Updates
3.1 Global Targeted Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023)
3.2 Global Targeted Radiopharmaceuticals Revenue by Manufacturer (2018-2023)
3.3 Global Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Targeted Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Targeted Radiopharmaceuticals Manufacturer Market Share in 2022
3.4.2 Top 6 Targeted Radiopharmaceuticals Manufacturer Market Share in 2022
3.5 Targeted Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 Targeted Radiopharmaceuticals Market: Region Footprint
3.5.2 Targeted Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 Targeted Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Targeted Radiopharmaceuticals Market Size by Region
4.1.1 Global Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2029)
4.1.2 Global Targeted Radiopharmaceuticals Consumption Value by Region (2018-2029)
4.1.3 Global Targeted Radiopharmaceuticals Average Price by Region (2018-2029)
4.2 North America Targeted Radiopharmaceuticals Consumption Value (2018-2029)
4.3 Europe Targeted Radiopharmaceuticals Consumption Value (2018-2029)
4.4 Asia-Pacific Targeted Radiopharmaceuticals Consumption Value (2018-2029)
4.5 South America Targeted Radiopharmaceuticals Consumption Value (2018-2029)
4.6 Middle East and Africa Targeted Radiopharmaceuticals Consumption Value (2018-2029)
5.1 Global Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
5.2 Global Targeted Radiopharmaceuticals Consumption Value by Type (2018-2029)
5.3 Global Targeted Radiopharmaceuticals Average Price by Type (2018-2029)
6.1 Global Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
6.2 Global Targeted Radiopharmaceuticals Consumption Value by Application (2018-2029)
6.3 Global Targeted Radiopharmaceuticals Average Price by Application (2018-2029)
7.1 North America Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
7.2 North America Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
7.3 North America Targeted Radiopharmaceuticals Market Size by Country
7.3.1 North America Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
7.3.2 North America Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
8.2 Europe Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
8.3 Europe Targeted Radiopharmaceuticals Market Size by Country
8.3.1 Europe Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
8.3.2 Europe Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Targeted Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Targeted Radiopharmaceuticals Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
10.2 South America Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
10.3 South America Targeted Radiopharmaceuticals Market Size by Country
10.3.1 South America Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
10.3.2 South America Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Targeted Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Targeted Radiopharmaceuticals Market Drivers
12.2 Targeted Radiopharmaceuticals Market Restraints
12.3 Targeted Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Targeted Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Radiopharmaceuticals
13.3 Targeted Radiopharmaceuticals Production Process
13.4 Targeted Radiopharmaceuticals Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Radiopharmaceuticals Typical Distributors
14.3 Targeted Radiopharmaceuticals Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Targeted Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Targeted Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Targeted Radiopharmaceuticals Product and Services
Table 6. Novartis Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Targeted Radiopharmaceuticals Product and Services
Table 11. Bayer Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bayer Recent Developments/Updates
Table 13. Lantheus Basic Information, Manufacturing Base and Competitors
Table 14. Lantheus Major Business
Table 15. Lantheus Targeted Radiopharmaceuticals Product and Services
Table 16. Lantheus Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Lantheus Recent Developments/Updates
Table 18. Institute for Radioelements (IRE) Basic Information, Manufacturing Base and Competitors
Table 19. Institute for Radioelements (IRE) Major Business
Table 20. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
Table 21. Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Institute for Radioelements (IRE) Recent Developments/Updates
Table 23. Radiomedix Basic Information, Manufacturing Base and Competitors
Table 24. Radiomedix Major Business
Table 25. Radiomedix Targeted Radiopharmaceuticals Product and Services
Table 26. Radiomedix Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Radiomedix Recent Developments/Updates
Table 28. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Curium Pharma Major Business
Table 30. Curium Pharma Targeted Radiopharmaceuticals Product and Services
Table 31. Curium Pharma Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Curium Pharma Recent Developments/Updates
Table 33. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Clarity Pharmaceuticals Major Business
Table 35. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 36. Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Clarity Pharmaceuticals Recent Developments/Updates
Table 38. ROTOP Basic Information, Manufacturing Base and Competitors
Table 39. ROTOP Major Business
Table 40. ROTOP Targeted Radiopharmaceuticals Product and Services
Table 41. ROTOP Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. ROTOP Recent Developments/Updates
Table 43. Ratio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Ratio Therapeutics Major Business
Table 45. Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 46. Ratio Therapeutics Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ratio Therapeutics Recent Developments/Updates
Table 48. Fusion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Fusion Pharmaceuticals Major Business
Table 50. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 51. Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Fusion Pharmaceuticals Recent Developments/Updates
Table 53. Perspective Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. Perspective Therapeutics Major Business
Table 55. Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 56. Perspective Therapeutics Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Perspective Therapeutics Recent Developments/Updates
Table 58. RayzeBio Basic Information, Manufacturing Base and Competitors
Table 59. RayzeBio Major Business
Table 60. RayzeBio Targeted Radiopharmaceuticals Product and Services
Table 61. RayzeBio Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. RayzeBio Recent Developments/Updates
Table 63. Alpha-9 Theranostics Basic Information, Manufacturing Base and Competitors
Table 64. Alpha-9 Theranostics Major Business
Table 65. Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
Table 66. Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Alpha-9 Theranostics Recent Developments/Updates
Table 68. Radiopharm Theranostics Basic Information, Manufacturing Base and Competitors
Table 69. Radiopharm Theranostics Major Business
Table 70. Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
Table 71. Radiopharm Theranostics Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Radiopharm Theranostics Recent Developments/Updates
Table 73. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Telix Pharmaceuticals Major Business
Table 75. Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 76. Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Telix Pharmaceuticals Recent Developments/Updates
Table 78. Ariceum Therapeutics Basic Information, Manufacturing Base and Competitors
Table 79. Ariceum Therapeutics Major Business
Table 80. Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
Table 81. Ariceum Therapeutics Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ariceum Therapeutics Recent Developments/Updates
Table 83. Aktis Oncology Basic Information, Manufacturing Base and Competitors
Table 84. Aktis Oncology Major Business
Table 85. Aktis Oncology Targeted Radiopharmaceuticals Product and Services
Table 86. Aktis Oncology Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Aktis Oncology Recent Developments/Updates
Table 88. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 89. Navidea Biopharmaceuticals Major Business
Table 90. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
Table 91. Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Navidea Biopharmaceuticals Recent Developments/Updates
Table 93. Nucleus RadioPharma Basic Information, Manufacturing Base and Competitors
Table 94. Nucleus RadioPharma Major Business
Table 95. Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
Table 96. Nucleus RadioPharma Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Nucleus RadioPharma Recent Developments/Updates
Table 98. SmartNuclide Biopharma Basic Information, Manufacturing Base and Competitors
Table 99. SmartNuclide Biopharma Major Business
Table 100. SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
Table 101. SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. SmartNuclide Biopharma Recent Developments/Updates
Table 103. TetraKit Technologies Basic Information, Manufacturing Base and Competitors
Table 104. TetraKit Technologies Major Business
Table 105. TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
Table 106. TetraKit Technologies Targeted Radiopharmaceuticals Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. TetraKit Technologies Recent Developments/Updates
Table 108. Global Targeted Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 109. Global Targeted Radiopharmaceuticals Revenue by Manufacturer (2018-2023) & (USD Million)
Table 110. Global Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 111. Market Position of Manufacturers in Targeted Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 112. Head Office and Targeted Radiopharmaceuticals Production Site of Key Manufacturer
Table 113. Targeted Radiopharmaceuticals Market: Company Product Type Footprint
Table 114. Targeted Radiopharmaceuticals Market: Company Product Application Footprint
Table 115. Targeted Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 116. Targeted Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
Table 118. Global Targeted Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
Table 119. Global Targeted Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
Table 120. Global Targeted Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
Table 121. Global Targeted Radiopharmaceuticals Average Price by Region (2018-2023) & (US$/Unit)
Table 122. Global Targeted Radiopharmaceuticals Average Price by Region (2024-2029) & (US$/Unit)
Table 123. Global Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 124. Global Targeted Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 125. Global Targeted Radiopharmaceuticals Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Global Targeted Radiopharmaceuticals Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Global Targeted Radiopharmaceuticals Average Price by Type (2018-2023) & (US$/Unit)
Table 128. Global Targeted Radiopharmaceuticals Average Price by Type (2024-2029) & (US$/Unit)
Table 129. Global Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Global Targeted Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Global Targeted Radiopharmaceuticals Consumption Value by Application (2018-2023) & (USD Million)
Table 132. Global Targeted Radiopharmaceuticals Consumption Value by Application (2024-2029) & (USD Million)
Table 133. Global Targeted Radiopharmaceuticals Average Price by Application (2018-2023) & (US$/Unit)
Table 134. Global Targeted Radiopharmaceuticals Average Price by Application (2024-2029) & (US$/Unit)
Table 135. North America Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 136. North America Targeted Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 137. North America Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 138. North America Targeted Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 139. North America Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
Table 140. North America Targeted Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
Table 141. North America Targeted Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
Table 142. North America Targeted Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Europe Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 144. Europe Targeted Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 145. Europe Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 146. Europe Targeted Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 147. Europe Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
Table 148. Europe Targeted Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
Table 149. Europe Targeted Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Targeted Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 152. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 153. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 154. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 155. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
Table 156. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
Table 157. Asia-Pacific Targeted Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
Table 158. Asia-Pacific Targeted Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
Table 159. South America Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 160. South America Targeted Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 161. South America Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 162. South America Targeted Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 163. South America Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2023) & (K Units)
Table 164. South America Targeted Radiopharmaceuticals Sales Quantity by Country (2024-2029) & (K Units)
Table 165. South America Targeted Radiopharmaceuticals Consumption Value by Country (2018-2023) & (USD Million)
Table 166. South America Targeted Radiopharmaceuticals Consumption Value by Country (2024-2029) & (USD Million)
Table 167. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2023) & (K Units)
Table 168. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Type (2024-2029) & (K Units)
Table 169. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2023) & (K Units)
Table 170. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Application (2024-2029) & (K Units)
Table 171. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2023) & (K Units)
Table 172. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Region (2024-2029) & (K Units)
Table 173. Middle East & Africa Targeted Radiopharmaceuticals Consumption Value by Region (2018-2023) & (USD Million)
Table 174. Middle East & Africa Targeted Radiopharmaceuticals Consumption Value by Region (2024-2029) & (USD Million)
Table 175. Targeted Radiopharmaceuticals Raw Material
Table 176. Key Manufacturers of Targeted Radiopharmaceuticals Raw Materials
Table 177. Targeted Radiopharmaceuticals Typical Distributors
Table 178. Targeted Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Targeted Radiopharmaceuticals Picture
Figure 2. Global Targeted Radiopharmaceuticals Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Targeted Radiopharmaceuticals Consumption Value Market Share by Type in 2022
Figure 4. Targeted Therapeutic Radiopharmaceuticals Examples
Figure 5. Targeted Diagnostic Radiopharmaceuticals Examples
Figure 6. Global Targeted Radiopharmaceuticals Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Targeted Radiopharmaceuticals Consumption Value Market Share by Application in 2022
Figure 8. Targeted Therapy Examples
Figure 9. Targeted Diagnosis Examples
Figure 10. Global Targeted Radiopharmaceuticals Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Targeted Radiopharmaceuticals Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Targeted Radiopharmaceuticals Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Targeted Radiopharmaceuticals Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Targeted Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Targeted Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Targeted Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Targeted Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Targeted Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Targeted Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Targeted Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Targeted Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Targeted Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Targeted Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Targeted Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Targeted Radiopharmaceuticals Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Targeted Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Targeted Radiopharmaceuticals Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Targeted Radiopharmaceuticals Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Targeted Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Targeted Radiopharmaceuticals Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Targeted Radiopharmaceuticals Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Targeted Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Targeted Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Targeted Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Targeted Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Targeted Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Targeted Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Targeted Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Targeted Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Targeted Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
Figure 52. China Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Targeted Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Targeted Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Targeted Radiopharmaceuticals Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Targeted Radiopharmaceuticals Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Targeted Radiopharmaceuticals Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Targeted Radiopharmaceuticals Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Targeted Radiopharmaceuticals Market Drivers
Figure 73. Targeted Radiopharmaceuticals Market Restraints
Figure 74. Targeted Radiopharmaceuticals Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Targeted Radiopharmaceuticals in 2022
Figure 77. Manufacturing Process Analysis of Targeted Radiopharmaceuticals
Figure 78. Targeted Radiopharmaceuticals Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis Bayer Lantheus Institute for Radioelements (IRE) Radiomedix Curium Pharma Clarity Pharmaceuticals ROTOP Ratio Therapeutics Fusion Pharmaceuticals Perspective Therapeutics RayzeBio Alpha-9 Theranostics Radiopharm Theranostics Telix Pharmaceuticals Ariceum Therapeutics Aktis Oncology Navidea Biopharmaceuticals Nucleus RadioPharma SmartNuclide Biopharma TetraKit Technologies
Related Reports
08 Aug 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
